FAQ: AI Maverick Intel's Ticker Change and AI-Focused Rebrand

What is the main announcement in this content?

AI Maverick Intel announced that its common shares will begin trading on the OTC Market under the new ticker AIMV effective October 20, 2025, following the company’s rebranding from Bionoid Pharma to AI Maverick Intel.

Why is the company changing its ticker symbol?

The ticker change from BINP to AIMV aligns the company’s market identity with its mission to drive customer acquisition and revenue growth through its AI Maverick platform, reflecting its evolution into an AI-powered company.

When does the new ticker symbol take effect?

The new ticker symbol AIMV becomes effective on October 20, 2025.

What was the company’s previous name and what does it do now?

The company was previously known as Bionoid Pharma and has rebranded to AI Maverick Intel, now focusing on acquiring and optimizing revenue-generating businesses through its proprietary AI Maverick platform across various industries.

Who is the CEO of AI Maverick Intel and what did they say about the change?

CEO Wayne Cockburn stated that the new symbol reflects the company’s evolution into an AI-powered platform focused on partner-led deal flow and intelligent growth.

What industries does AI Maverick Intel serve with its AI platform?

The company enables intelligent engagement across healthcare, biotech, insurance, transportation and other verticals through its AI Maverick platform.

Where can investors find more information about AI Maverick Intel?

The latest news and updates relating to AIMV are available in the company’s newsroom at http://ibn.fm/AIMV, and the full press release can be viewed at https://ibn.fm/3AyH7.

What is the significance of this rebranding for the company’s future direction?

The rebranding signifies the company’s strategic shift to focus entirely on artificial intelligence solutions for customer acquisition and revenue growth, positioning itself as an AI-powered platform rather than its previous pharmaceutical focus.

What markets does AI Maverick Intel’s platform target?

The AI Maverick platform targets businesses seeking customer acquisition and revenue growth through intelligent, two-way engagement across multiple industries including healthcare, biotech, insurance, and transportation.